Capstar Special Purpose Acquisition Corp (CPSR) Peer Comparison
$26.11
$0.00 (0.00%)As on 26-Aug-2026 09:46EDT
Market cap
$254 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
0 %
Edit
| Capstar Special Purpose Acquisition Corp (CPSR) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
254 | 5,723 | 3,425 | 812 | 427 |
Revenue ($ Mln) |
-- | 440 | 2,883 | -- | 58 |
Net Profit ($ Mln) |
12.96 | -1,435.01 | -118.30 | -134.20 | -50.70 |
Net Margin (%) |
683.53 | -325.91 | -4.10 | -- | -88.09 |
RoE (%) |
-- | -- | -- | -40.17 | -54.90 |
Price to Earnings |
-- | -- | -- | -- | -- |
Price-To-Book |
1.48 | -- | 1.35 | -- | 2.89 |
Income Statement ($ Mln)
| Capstar Special Purpose Acquisition Corp (CPSR) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 60.32 | 1,912.90 | 64.89 | 18.98 |
|
Cost of Revenue
|
0.00 | 50.93 | 1,220.00 | -- | 12.61 |
|
Gross Profit
|
-- | 9.39 | 692.90 | 64.89 | 6.37 |
|
Operating Expenses
|
1.82 | 21.60 | 597.00 | 120.07 | 27.57 |
|
Operating Profit (EBIT)
|
-4.06 | -6.33 | 95.90 | -55.18 | -21.21 |
|
Other Income
|
1.90 | -- | -- | 2.46 | -- |
|
Profit before Tax
|
12.95 | -12.21 | -17.90 | -55.36 | -21.81 |
|
Provision for Tax
|
-0.01 | -4.97 | 17.30 | -- | -- |
|
Profit after Tax (Net Income)
|
12.96 | -12.21 | -19.60 | -55.36 | -21.81 |
|
Minority Interest
|
0.00 | -- | -- | -- | -- |
|
Consolidated Profit
|
-20.29 | -22.68 | -- | -55.36 | -0.01 |
Liabilities ($ Mln)
| Capstar Special Purpose Acquisition Corp (CPSR) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-44.31 | 133.70 | -236.90 | 385.61 | -107.82 |
|
Minority Interest
|
0.00 | -- | -- | -- | -- |
|
Non-Current Liabilities
|
42.05 | 22.23 | 2,346.70 | 81.73 | 128.39 |
|
Current Liabilities
|
2.76 | 69.65 | 1,360.30 | 51.56 | 12.13 |
|
Total Liabilities
|
276.77 | 225.58 | 3,690.80 | 518.90 | 32.69 |
Assets ($ Mln)
| Capstar Special Purpose Acquisition Corp (CPSR) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
276.18 | 154.66 | 2,762.50 | 77.33 | 4.79 |
|
Current Assets
|
0.34 | 70.92 | 928.30 | 441.57 | 27.90 |
|
Total Assets
|
276.77 | 225.58 | 3,690.80 | 518.90 | 32.69 |
|
Total Debt*
|
0.00 | 40.29 | 2,353.70 | 63.92 | 8.73 |
|
Net Current Assets
|
-2.42 | 1.27 | -- | 390.01 | -0.15 |
Cashflow ($ Mln)
| Capstar Special Purpose Acquisition Corp (CPSR) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-0.94 | -23.77 | -232.40 | -81.14 | -26.45 |
|
Cash Flow from Investing Activities
|
-301.09 | -15.14 | -0.30 | -282.36 | -3.43 |
|
Cash from Financing Activities
|
302.57 | 40.72 | 365.00 | 356.62 | 35.58 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -6.88 | -- |
Ratios
Profitability Ratios
| Capstar Special Purpose Acquisition Corp (CPSR) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-- | -7.69 | -- | -20.62 | 48.58 |
|
ROE (%)
|
-- | -9.06 | -- | -24.51 | 40.84 |
|
ROA (%)
|
4.58 | -6.30 | -- | -15.21 | -80.28 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
683.53 | -20.24 | -1.02 | -82.19 | -114.92 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Capstar Special Purpose Acquisition Corp (CPSR) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 0.01 | -- | 0.80 | 0.25 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-- | -2.38 | -- | 0.24 | 15.08 |
|
EPS Growth (%)
|
-- | -- | -- | 0.14 | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Capstar Special Purpose Acquisition Corp (CPSR) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | -- | -73.83 | -- |
|
Price / Book Value
|
-- | -- | -- | 10.60 | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-- | -- | -- | -71.54 | -- |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Capstar Special Purpose Acquisition Corp (CPSR) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.30 | -9.94 | 0.17 | -0.08 |
|
Short term debt to equity ratio
|
0.00 | 0.14 | -1.65 | 0.02 | -0.04 |
|
Current Ratio
|
0.12 | 1.02 | 0.68 | 8.56 | 2.30 |
|
Quick Ratio
|
0.12 | 0.18 | -- | -- | 1.70 |
|
Interest Coverage
|
-- | -1.75 | 0.84 | -19.94 | -33.19 |
Operating Efficiency Ratios
| Capstar Special Purpose Acquisition Corp (CPSR) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 1.84 | 23.89 | 0.26 | 22.48 |
|
Asset Turnover
|
0.00 | 0.31 | -- | 0.18 | 0.70 |
|
Receivable days
|
-- | 4.22 | 395.47 | 0.97 | 65.24 |
|
Inventory Days
|
-- | 418.19 | -- | -- | 172.01 |
|
Payable days
|
-- | 37.87 | 46.08 | -- | 42.61 |
|
Cash Conversion Cycle
|
-- | 384.55 | -- | -- | 194.64 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
